Free Trial
OTCMKTS:PCHM

PharmChem 4/30/2024 Earnings Report

$3.54 -0.16 (-4.24%)
As of 05/28/2025 02:38 PM Eastern

PharmChem EPS Results

Actual EPS
$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$1.45 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

PharmChem's next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Conference Call Resources

PharmChem Earnings Headlines

How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
PharmChem considers strategic alternatives
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM) provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

View PharmChem Profile

More Earnings Resources from MarketBeat